BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 12957435)

  • 1. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
    Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
    Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
    Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters.
    Di Salvo G; Pacileo G; Limongelli G; Baldini L; Rea A; Verrengia M; D'Andrea A; Russo MG; Calabrò R
    J Am Soc Echocardiogr; 2010 Jun; 23(6):581-90. PubMed ID: 20362415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
    Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
    Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy.
    He Y; Zhou J
    Am J Cardiol; 2024 Jan; 210():195-200. PubMed ID: 37884111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.
    Doval HC; Nul DR; Grancelli HO; Varini SD; Soifer S; Corrado G; Dubner S; Scapin O; Perrone SV
    Circulation; 1996 Dec; 94(12):3198-203. PubMed ID: 8989129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Chan RH; Adler A; Care M; Chauhan V; Gollob MH; Ziv-Baran T; Fourey D; Hindieh W; Rakowski H; Spears DA
    Am J Cardiol; 2016 Oct; 118(8):1258-1263. PubMed ID: 27567133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
    Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.